Wealth Enhancement Advisory Services »

Summit Therapeutics shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2025-12-31 $390k 21k 18.66
2025-09-30 $366k 16k 22.29
2025-06-30 $260k 11k 24.55

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Broadcom (AVGO)
Ishares Tr Core Us Aggbd Et (AGG)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Intl Moment (IMTM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Msci Usa Min Vol (USMV)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Susquehanna International
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Norges Bank Investment Management
Apeiron Capital
Nomura Holdings
TD Asset Management
Standard Life Aberdeen
Charles Schwab Investment Management

View all funds holding Summit Therapeutics